Medtronic plcMDTNYSE
LOADING
|||
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +5.25% | +2.51% | +3.94% | +8.38% | +6.64% |
| Gross Profit Growth | +4.48% | +3.88% | +4.24% | -4.04% | -0.95% |
| EBITDA Growth | +12.84% | +4.07% | +32.96% | +6.10% | -3.15% |
| Operating Income Growth | +19.03% | +10.99% | +36.37% | +13.07% | +5.64% |
| Net Income Growth | +39.71% | -2.12% | +61.62% | -0.19% | +8.19% |
| EPS Growth | +45.59% | +2.02% | +67.35% | +0.00% | +8.08% |
| EPS Diluted Growth | +45.59% | +2.02% | +67.35% | +1.25% | +8.08% |
| Weighted Average Shares Growth | -3.59% | -3.56% | -3.03% | -0.90% | -0.05% |
| Weighted Average Shares Diluted Growth | -3.38% | -3.42% | -2.84% | -0.73% | +0.05% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +44.93% | +3.96% | -8.97% | +10.34% | -3.44% |
| Free Cash Flow Growth | +177.00% | -1.50% | -11.99% | +25.32% | -17.51% |
| Receivables Growth | +5.49% | +2.46% | +6.32% | +4.19% | +2.06% |
| Inventory Growth | -4.78% | -2.03% | +4.96% | -106.89% | +12.36% |
| Asset Growth | -0.05% | -0.95% | +1.89% | +1.36% | +1.45% |
| Book Value per Share Growth | -2.25% | -1.13% | -1.38% | +0.80% | +0.37% |
| Debt Growth | +12.94% | +5.66% | +13.95% | +2.67% | +2.73% |
| R&D Expense Growth | -0.14% | -2.88% | +1.33% | +7.40% | +8.18% |
| SG&A Expenses Growth | +2.64% | +1.65% | -1.63% | +5.69% | +7.58% |